{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:09:38Z","timestamp":1793419778737,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15K08095"],"award-info":[{"award-number":["15K08095"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.pharmthera.2021.108023","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T18:45:14Z","timestamp":1634582714000},"page":"108023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Recent advances in riboflavin transporter RFVT and its genetic disease"],"prefix":"10.1016","volume":"233","author":[{"given":"Congyun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.108023_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079937","article-title":"Association of the plasma and tissue riboflavin levels with C20orf54 expression in cervical lesions and its relationship to HPV16 infection","volume":"8","author":"Aili","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0010","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s11033-012-2453-7","article-title":"Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients","volume":"40","author":"Ainiwaer","year":"2013","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0883073816689517","article-title":"Brown-Vialetto-Van Laere syndrome as a mimic of Neuroimmune disorders: 3 cases from the clinic and review of the literature","volume":"32","author":"Allison","year":"2017","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0887-8994(02)00376-4","article-title":"A novel chronic childhood sensory predominant neuropathy","volume":"27","author":"Al-Twaijri","year":"2002","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijporl.2017.11.014","article-title":"SLC52A2 mutations cause SCABD2 phenotype: A second report","volume":"104","author":"Babanejad","year":"2018","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0030","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/ene.12163","article-title":"A novel compound heterozygous mutation of C20orf54 gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family","volume":"20","author":"Bandettini di Poggio","year":"2013","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/21678421.2013.837931","article-title":"Brown-Vialetto-Van Laere syndrome: Clinical and neuroradiological findings of a genetically proven patient","volume":"15","author":"Bandettini Di Poggio","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fphar.2019.00079","article-title":"Evaluation of riboflavin transporters as targets for drug delivery and Theranostics","volume":"10","author":"Bartmann","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/practneurol-2016-001488","article-title":"Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome","volume":"17","author":"Bashford","year":"2017","journal-title":"Practical Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acs.bioconjchem.6b00317","article-title":"Amphiphilic phospholipid-based riboflavin derivatives for tumor targeting Nanomedicines","volume":"27","author":"Beztsinna","year":"2016","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: A new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: Natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch","year":"2012","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000215","article-title":"Late-onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family","volume":"4","author":"Camargos","year":"2018","journal-title":"Neurol Genet"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/acn3.50977","article-title":"A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment","volume":"7","author":"Carreau","year":"2020","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jnnp-2020-323304","article-title":"Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies","volume":"92","author":"Carreau","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.spen.2017.03.002","article-title":"The first Case of riboflavin transporter deficiency in sub-Saharan Africa","volume":"26","author":"Chaya","year":"2018","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12883-019-1562-5","article-title":"Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): Case reports and epidemiology of ETFDH gene mutations","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0090","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.nmd.2012.05.007","article-title":"Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: A clinical, biochemical and genetic study","volume":"22","author":"Ciccolella","year":"2012","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmedgenet-2012-101204","article-title":"Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: Two novel mutations","volume":"50","author":"Ciccolella","year":"2013","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0100","first-page":"A181","article-title":"P38U hypotonic infant with riboflavin transporter deficiency due to slc52a2 mutations","volume":"102","author":"\u00c7\u0131ral\u0131","year":"2017","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0105","first-page":"9","article-title":"Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency","author":"Colasuonno","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184416","article-title":"Reconstitution in Proteoliposomes of the recombinant human riboflavin transporter 2 (SLC52A2) overexpressed in E. coli","volume":"20","author":"Console","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2014.10.016","article-title":"Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: A case report","volume":"128","author":"Cosgrove","year":"2015","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1203\/00006450-198511000-00002","article-title":"Transfer of riboflavin by the perfused human placenta","volume":"19","author":"Dancis","year":"1985","journal-title":"Pediatric Research"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jn\/113.3.636","article-title":"In vitro kinetics of the intestinal transport of riboflavin in rats","volume":"113","author":"Daniel","year":"1983","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0130","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.bioconjchem.0c00593","article-title":"Influence of riboflavin targeting on tumor accumulation and internalization of Peptostar based drug delivery systems","volume":"31","author":"Darguzyte","year":"2020","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2014-310088","article-title":"Brown-Vialetto-Van Laere syndrome: A 28-year follow-up","volume":"87","author":"Davis","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/jhg.2012.70","article-title":"Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients","volume":"57","author":"Dezfouli","year":"2012","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0145","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/acs.jcim.9b01020","article-title":"In Silico identification of a key residue for substrate recognition of the riboflavin membrane transporter RFVT3","volume":"60","author":"Dilly","year":"2020","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40673-018-0091-0","article-title":"Successful treatment of a genetic childhood ataxia due to riboflavin transporter deficiency","volume":"5","author":"Fan","year":"2018","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaneurol.2014.1944","article-title":"Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia","volume":"71","author":"Fogel","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0165","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/WNR.0000000000000674","article-title":"Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma","volume":"27","author":"Fu","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0170","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3945\/jn.110.128330","article-title":"Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption","volume":"140","author":"Fujimura","year":"2010","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/JPN.JPN_131_17","article-title":"Riboflavin treatment in genetically proven Brown-Vialetto-Van Laere syndrome","volume":"13","author":"Garg","year":"2018","journal-title":"Journal of Pediatric Neurosciences"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ene.14682","article-title":"Brown-Vialetto-Van Laere and Fazio-Londe syndromes: SLC52A3 mutations with puzzling phenotypes and inheritance","volume":"28","author":"Gayathri","year":"2021","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: New function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0190","doi-asserted-by":"crossref","first-page":"G1052","DOI":"10.1152\/ajpgi.00314.2012","article-title":"Mechanism and regulation of vitamin B2 (riboflavin) uptake by mouse and human pancreatic beta-cells\/islets: Physiological and molecular aspects","volume":"303","author":"Ghosal","year":"2012","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2018.10.017","article-title":"Oral therapy for riboflavin transporter deficiency - what is the regimen of choice?","volume":"61","author":"Gorcenco","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0200","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.braindev.2018.02.010","article-title":"Fazio-Londe syndrome in siblings from India with different phenotypes","volume":"40","author":"Gowda","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green","year":"2010","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0210","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ejhg.2015.259","article-title":"Genes for spinocerebellar ataxia with blindness and deafness (SCABD\/SCAR3, MIM# 271250 and SCABD2)","volume":"24","author":"Guissart","year":"2016","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126124","article-title":"Extensive identification of bacterial riboflavin transporters and their distribution across bacterial species","volume":"10","author":"Gutierrez-Preciado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0220","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-012-9513-y","article-title":"Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome","volume":"35","author":"Haack","year":"2012","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0225","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1167\/iovs.19-27328","article-title":"Quantitative protein expression in the human retinal pigment epithelium: Comparison between apical and Basolateral plasma membranes with emphasis on transporters","volume":"60","author":"Hellinen","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0230","doi-asserted-by":"crossref","first-page":"E1976","DOI":"10.1002\/humu.21399","article-title":"Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B","volume":"32","author":"Ho","year":"2011","journal-title":"Human Mutation"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/jpem-2015-0198","article-title":"Brown-Vialetto-Van Laere syndrome: Two siblings with a new mutation and dramatic therapeutic effect of high-dose riboflavin","volume":"29","author":"Horoz","year":"2016","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jn\/41.2.247","article-title":"Correlation of urinary excretion of riboflavin with dietary intake and symptoms of ariboflavinosis","volume":"41","author":"Horwitt","year":"1950","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0245","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/hgv.2017.18","article-title":"Early onset of Fazio-Londe syndrome: The first case report from the Arabian peninsula","volume":"4","author":"Hossain","year":"2017","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0250","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/hmg\/ddw053","article-title":"SLC52A3, a Brown-Vialetto-van Laere syndrome candidate gene is essential for mouse development, but dispensable for motor neuron differentiation","volume":"25","author":"Intoh","year":"2016","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0255","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger","year":"2016","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2014.07.013","article-title":"RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death","volume":"353","author":"Jiang","year":"2014","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1248\/bpb.b20-00751","article-title":"Complete deletion of Slc52a2 causes embryonic lethality in mice","volume":"44","author":"Jin","year":"2021","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0270","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1248\/bpb.b17-00292","article-title":"Riboflavin transporters RFVT\/SLC52A mediate translocation of riboflavin, rather than FMN or FAD, across plasma membrane","volume":"40","author":"Jin","year":"2017","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0275","doi-asserted-by":"crossref","first-page":"18443","DOI":"10.1038\/s41598-020-75601-9","article-title":"Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice","volume":"10","author":"Jin","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0280","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/brain\/aws161","article-title":"Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease","volume":"135","author":"Johnson","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajhg.2010.05.021","article-title":"Exome sequencing in Brown-Vialetto-van Laere syndrome","volume":"87","author":"Johnson","year":"2010","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0290","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1002\/mus.25694","article-title":"Reversible posterior column dysfunction in Brown-Vialetto-Von Laere syndrome","volume":"56","author":"Khadilkar","year":"2017","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0295","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pediatrneurol.2012.03.008","article-title":"Brown-Vialetto-Van Laere syndrome: A riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene","volume":"46","author":"Koy","year":"2012","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0300","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4103\/0028-3886.299175","article-title":"Brown-Vialetto-Van Laere syndrome: A rare case report of MND mimic","volume":"68","author":"Kranthi","year":"2020","journal-title":"Neurology India"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.dmpk.2019.08.002","article-title":"Riboflavin transport mediated by riboflavin transporters (RFVTs\/SLC52A) at the rat outer blood-retinal barrier","volume":"34","author":"Kubo","year":"2019","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.dmpk.2016.09.006","article-title":"Blood-to-retina transport of riboflavin via RFVTs at the inner blood-retinal barrier","volume":"32","author":"Kubo","year":"2017","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0315","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.ejpn.2017.04.1025","article-title":"Case report of patients with Fazio-Londe syndrome","volume":"21","author":"Kurkina","year":"2017","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0320","doi-asserted-by":"crossref","first-page":"G589","DOI":"10.1152\/ajpgi.00238.2017","article-title":"Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3","volume":"313","author":"Lakhan","year":"2017","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0325","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00018-018-2757-4","article-title":"SLC52A3 expression is activated by NF-\u03baB p65\/Rel-B and serves as a prognostic biomarker in esophageal cancer","volume":"75","author":"Long","year":"2018","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0330","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.7314\/APJCP.2014.15.6.2485","article-title":"Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women","volume":"15","author":"Ma","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0335","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/brain\/awx231","article-title":"Clinical, pathological and functional characterization of riboflavin-responsive neuropathy","volume":"140","author":"Manole","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0340","first-page":"21","article-title":"Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells","author":"Marioli","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0345","first-page":"13339","article-title":"Correlation analysis of riboflavin, RFT2 and Helicobater pylori in gastric carcinoma","volume":"8","author":"Matnuri","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-8628(20000515)92:2<117::AID-AJMG7>3.0.CO;2-C","article-title":"Brown-Vialetto-Van Laere syndrome in a large inbred Lebanese family: Confirmation of autosomal recessive inheritance?","volume":"92","author":"Megarbane","year":"2000","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0355","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clinph.2015.05.012","article-title":"Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter","volume":"127","author":"Menezes","year":"2016","journal-title":"Clinical Neurophysiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0360","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/dmcn.13084","article-title":"Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency","volume":"58","author":"Menezes","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0365","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymgme.2017.10.014","article-title":"An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"122","author":"Mosegaard","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.915","article-title":"FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening","volume":"7","author":"Muru","year":"2019","journal-title":"Molecular Genetics & Genomic Medicine"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0375","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ymgme.2011.12.021","article-title":"Effect of clinical mutations on functionality of the human riboflavin transporter-2 (hRFT-2)","volume":"105","author":"Nabokina","year":"2012","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0380","series-title":"Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency","author":"Niceforo","year":"2021"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0385","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.a.38530","article-title":"Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency","volume":"176","author":"Nimmo","year":"2018","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Human Mutation"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0395","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0400","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-responsive and -non-responsive mutations in FAD synthase cause multiple acyl-CoA dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.05.052","article-title":"Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells","volume":"1468","author":"Patel","year":"2012","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0410","doi-asserted-by":"crossref","first-page":"a000257","DOI":"10.1101\/mcs.a000257","article-title":"Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition","volume":"1","author":"Petrovski","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0415","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/ajmg.a.61851","article-title":"Hematologic presentation and the role of untargeted metabolomics analysis in monitoring treatment for riboflavin transporter deficiency","volume":"182","author":"Pillai","year":"2020","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0420","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/ajcn\/77.6.1352","article-title":"Riboflavin (vitamin B-2) and health","volume":"77","author":"Powers","year":"2003","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0425","doi-asserted-by":"crossref","first-page":"46271","DOI":"10.1038\/srep46271","article-title":"Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin","volume":"7","author":"Rizzo","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0430","first-page":"27","article-title":"A riboflavin transporter in Bdellovibrio exovorous JSS","volume":"29","author":"Rodionova","year":"2019","journal-title":"Journal of Molecular Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0435","first-page":"37","article-title":"A novel truncating FLAD1 variant, causing multiple acyl-CoA dehydrogenase deficiency (MADD) in an 8-year-old boy","volume":"45","author":"Ryder","year":"2019","journal-title":"JIMD Rep"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0440","doi-asserted-by":"crossref","first-page":"C805","DOI":"10.1152\/ajpcell.00029.2019","article-title":"Identification of transmembrane protein 237 as a novel interactor with the intestinal riboflavin transporter-3 (RFVT-3): Role in functionality and cell biology","volume":"316","author":"Sabui","year":"2019","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0016-5085(91)90586-A","article-title":"Transport of riboflavin in human intestinal brush border membrane vesicles","volume":"100","author":"Said","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0450","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-2736(93)90138-P","article-title":"Uptake of riboflavin by intestinal basolateral membrane vesicles: A specialized carrier-mediated process","volume":"1148","author":"Said","year":"1993","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0455","first-page":"G15","article-title":"Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells","volume":"266","author":"Said","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12881-019-0811-1","article-title":"A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: Clinical course and response to riboflavin","volume":"20","author":"Shi","year":"2019","journal-title":"BMC Medical Genetics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0465","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mus.24224","article-title":"Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood","volume":"50","author":"Srour","year":"2014","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131698","article-title":"Molecular mechanisms mediating the adaptive regulation of intestinal riboflavin uptake process","volume":"10","author":"Subramanian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0475","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12986-015-0008-3","article-title":"Identification of residues\/sequences in the human riboflavin transporter-2 that is important for function and cell biology","volume":"12","author":"Subramanian","year":"2015","journal-title":"Nutrition & Metabolism (London)"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0480","doi-asserted-by":"crossref","first-page":"G285","DOI":"10.1152\/ajpgi.00340.2015","article-title":"Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption","volume":"310","author":"Subramanian","year":"2016","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0485","doi-asserted-by":"crossref","first-page":"G100","DOI":"10.1152\/ajpgi.00120.2011","article-title":"Role of cysteine residues in cell surface expression of the human riboflavin transporter-2 (hRFT2) in intestinal epithelial cells","volume":"301","author":"Subramanian","year":"2011","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0490","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10620-018-5305-z","article-title":"Sodium butyrate enhances intestinal riboflavin uptake via induction of expression of riboflavin Transporter-3 (RFVT3)","volume":"64","author":"Subramanian","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0495","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00089.2013","article-title":"Chronic alcohol feeding inhibits physiological and molecular parameters of intestinal and renal riboflavin transport","volume":"305","author":"Subramanian","year":"2013","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0500","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.bbamem.2011.08.004","article-title":"Differential expression of human riboflavin transporters \u22121, \u22122, and \u22123 in polarized epithelia: A key role for hRFT-2 in intestinal riboflavin uptake","volume":"1808","author":"Subramanian","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0505","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1080\/10408398.2016.1145104","article-title":"Riboflavin and health: A review of recent human research","volume":"57","author":"Thakur","year":"2017","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0510","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X17725610","article-title":"A Case of Brown-Vialetto-Van Laere syndrome due to a novel mutation in SLC52A3 gene: Clinical course and response to riboflavin","volume":"4","author":"Thulasi","year":"2017","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0515","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/107175401316906874","article-title":"Transport functions of riboflavin carriers in the rat small intestine and colon: Site difference and effects of tricyclic-type drugs","volume":"8","author":"Tomei","year":"2001","journal-title":"Drug Delivery"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0520","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.nanolett.7b01171","article-title":"Balancing passive and active targeting to different tumor compartments using riboflavin-functionalized polymeric Nanocarriers","volume":"17","author":"Tsvetkova","year":"2017","journal-title":"Nano Letters"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0525","first-page":"2659","article-title":"The expression of riboflavin transporters in human colorectal Cancer","volume":"38","author":"Tutino","year":"2018","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0530","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cca.2016.09.022","article-title":"SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters","volume":"462","author":"Udhayabanu","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0535","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.nmd.2016.06.416","article-title":"Riboflavin transporter deficiency diagnosed 30 years after onset of symptoms","volume":"26","author":"Van Der Kooi","year":"2016","journal-title":"Neuromuscular Disorders"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2021.108023_bb0540","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1007\/s10545-010-9246-8","article-title":"Novel ETF dehydrogenase mutations in a patient with mild glutaric aciduria type II and complex II-III deficiency in liver and muscle","volume":"33","author":"Wolfe","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0545","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2017.03.001","article-title":"Genetic, radiologic, and clinical variability in Brown-Vialetto-van Laere syndrome","volume":"26","author":"Woodcock","year":"2018","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0550","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jb\/mvn181","article-title":"Identification and functional characterization of rat riboflavin transporter 2","volume":"145","author":"Yamamoto","year":"2009","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0555","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1111\/jcmm.14409","article-title":"Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin","volume":"23","author":"Yang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0560","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/jn.110.122911","article-title":"Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain","volume":"140","author":"Yao","year":"2010","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0565","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejphar.2013.07.042","article-title":"Involvement of riboflavin transporter RFVT2\/Slc52a2 in hepatic homeostasis of riboflavin in mice","volume":"714","author":"Yao","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0570","doi-asserted-by":"crossref","first-page":"314","DOI":"10.24953\/turkjped.2021.02.016","article-title":"Brown Vialetto Van Laere syndrome: Presenting with left ventricular non-compaction and mimicking mitochondrial disorders","volume":"63","author":"Yilmaz","year":"2021","journal-title":"The Turkish Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0575","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.mam.2012.07.014","article-title":"Novel riboflavin transporter family RFVT\/SLC52: Identification, nomenclature, functional characterization and genetic diseases of RFVT\/SLC52","volume":"34","author":"Yonezawa","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0580","doi-asserted-by":"crossref","first-page":"C632","DOI":"10.1152\/ajpcell.00019.2008","article-title":"Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1","volume":"295","author":"Yonezawa","year":"2008","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0585","doi-asserted-by":"crossref","first-page":"27557","DOI":"10.1038\/srep27557","article-title":"Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice","volume":"6","author":"Yoshimatsu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108023_bb0590","doi-asserted-by":"crossref","first-page":"G102","DOI":"10.1152\/ajpgi.00349.2013","article-title":"Functional involvement of RFVT3\/SLC52A3 in intestinal riboflavin absorption","volume":"306","author":"Yoshimatsu","year":"2014","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:20:44Z","timestamp":1759011644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":118,"alternative-id":["S0163725821002254"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108023","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in riboflavin transporter RFVT and its genetic disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108023"}}